ArticleFrontiers in oncology2026
Histologic heterogeneity in synchronous bilateral breast cancer: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synchronous bilateral primary breast cancer (sBPBC) accounts for 2.9%-3.9% of newly diagnosed breast cancers, while cases with discordant histologic subtypes are exceptionally rare. We report on a 59-year-old woman with synchronous left-sided invasive ductal carcinoma (IDC) and right-sided invasive lobular carcinoma (ILC). The patient underwent bilateral breast-conserving surgery with sentinel lymph node biopsy, followed by adjuvant radiotherapy and endocrine therapy. No recurrence or metastasis was observed during the 12-month follow-up. To place the present case in the context of the existing literature, we comparatively reviewed seven previously reported cases of synchronous bilateral IDC and ILC. The comparison illustrated considerable heterogeneity in the clinicopathological characteristics, molecular profiles, nodal involvement, treatment strategies, and clinical outcomes. These findings support independent characterization of each breast lesion and individualized treatment planning based on the features of both tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.